The AmbioPharm API Model

AmbioPharm has developed a unique business model designed to handle expedited peptide manufacturing at a lower cost than most major competitors.

AmbioPharm USA Facility

Expanding Capacity locally in the USA and China

With one of the largest peptide manufacturing capacities in the world, AmbioPharm is currently expanding both in the USA and China. With the new construction, we are more than tripling our peptide synthesis capacity.

One of the largest peptide capacity manufacturers worldwide

In our FDA-inspected facilities, we employ more than 500 chemists and industry professionals at our two locations.  Superior chemistry and facilities enable us to provide best-in-class quality with efficient and timely production.

AmbioPharm peptide manufacturing lab

Built for large and small projects

We can produce projects of any scale.  AmbioPharm has multiple manufacturing suites capable of producing peptide APIs at varying scales from gram to multi-kilogram scale.  Recently, we have added a small-scale CEM Liberty Blue Microwave synthesizer to aid with small-scale non-GMP peptide projects. This helps speed delivery of these early stage projects to our partners to facilitate their discovery efforts.

Take your project from R&D to Commercial

AmbioPharm has handled products in every phase of development from pre-clinical to R&D to commercialization, including analytical method and validation protocol services.


Products & Services

The professionals at AmbioPharm have more than 150 years of cumulative experience in process development, scale up, and GMP services.

We provide process development and analytical services for non-GMP grade peptides for a broad range of customers.

AmbioPharm partners with generic drug companies to develop generic peptide drugs for established commercial markets throughout the world.

AmbioPharm has years of experience manufacturing Active Peptide Ingredients for peptide vaccines in varying configurations.

During the development process is underway, we develop analytical HPLC methods and write the analytical method validation protocol.

AmbioPharm has the scale and quality systems in place to meet the stringent needs of the cosmetic formulation industry.  With experience in all types of peptide synthesis from solid phase to liquid (or solution) phase or a hybrid of strategies, we can synthesize the simplest to most complex cosmetic peptide ingredients.

Who We Serve

We provide products and services to Pharmaceutical companies, Clinical Research labs, Universities, Biotech companies, and others.

Pharmaceutical Companies

We manufacture peptide APIs for some of the world’s largest pharmaceutical companies, but we can also handle small batch projects. 

Clinical Research Labs

AmbioPharm produces peptide products to cGMP standards and provides process development and analytical services for non-GMP peptides.

Upcoming Events

Biologics UK: Peptides Congress 

Mar 21 - 23 2022

London, UK


CPhI China

Jun 21 - 23 2022

Shanghai, China



For Peptide API Manufacturing and Services

Have a Peptide project?